Tonga
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Tonga (TO)
2000 | 7.5 thousand |
2011 | 6.1 thousand |
2024 | 10.1 thousand |
2050 | 15.1 thousand |
Tonga is one of the 37 countries and territories in the Western Pacific Region.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPS 2017
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 7.5 | 6.1 | 10.1 | 15.1 |
Age-standardised prevalence of diabetes, % | 11.5 | 12.7 | 19.6 | 23.1 |
Proportion of people with undiagnosed diabetes, % | - | - | 73.2 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 7.4 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 0.9 | 1.2 |
Age-standardised prevalence of IFG, % | - | - | 1.5 | 1.5 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 3.8 | 4.8 | 6.8 |
Age-standardised prevalence of IGT, % | - | 7.7 | 8.8 | 9.4 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 98.0 | 64.9 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 14.6 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 4.5 | 6.2 |
Total diabetes-related health expenditure, ID million | - | - | 6.7 | 9.3 |
Diabetes-related health expenditure per person, USD | - | 221.0 | 444.1 | 411.6 |
Diabetes-related health expenditure per person, ID | - | - | 666.0 | 617.4 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 4.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 1.6 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 65.0 | 53.0 | 59.3 | 80.2 |
Population of children and adolescents (0-19 y) | - | - | 48,438.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 7.5 |
Age-standardised prevalence of diabetes, % | 11.5 |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 65.0 |
Population of children and adolescents (0-19 y) | - |